Trial Profile
Identification of Biomarkers for Prediction of Hepatocellular Carcinoma after Elimination of Hepatitis C Virus by Antiviral Medicine, Harvoni
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Biomarker; Pharmacodynamics
- 25 Nov 2015 New trial record